Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-20118 in Moderate to Severe Plaque Psoriasis
NCT07765628Phase 2Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Aug 2026
- Primary completion
- Feb 2027
01
Overview
A Phase 2 trial of HS-20118 in plaque psoriasis, sponsored by Hansoh Pharmaceutical Group. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
HS-20118
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07765628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765628.